Cleared Abbreviated

K240348 - Quantum Mitohormesis (QMT) (M2101) (FDA 510(k) Clearance)

Dec 2024
Decision
318d
Days
Class 2
Risk

K240348 is an FDA 510(k) clearance for the Quantum Mitohormesis (QMT) (M2101). This device is classified as a Stimulator, Muscle, Powered (Class II - Special Controls, product code IPF).

Submitted by Quantumtx Pte. , Ltd. (Singapore, SG). The FDA issued a Cleared decision on December 19, 2024, 318 days after receiving the submission on February 5, 2024.

This device falls under the Physical Medicine FDA review panel. Regulated under 21 CFR 890.5850.

Submission Details

510(k) Number K240348 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 05, 2024
Decision Date December 19, 2024
Days to Decision 318 days
Submission Type Abbreviated
Review Panel Physical Medicine (PM)
Summary Summary PDF

Device Classification

Product Code IPF - Stimulator, Muscle, Powered
Device Class Class II - Special Controls
CFR Regulation 21 CFR 890.5850